drugset / Trial / NCT07079579
Enarodustat Tablets at Different Initial Doses for Anemia in Non-dialysis CKD Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
To evaluate the rationality of different initial doses of enarodustat for the treatment of anemia in ND-CKD patients
Timeline
- Start
- 2025-08
- Primary completion
- 2027-06
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Enarodustat | Small molecule | 2 mg | — |
| Subject | Enarodustat | Small molecule | 3 mg | — |
| Subject | Enarodustat | Small molecule | 4 mg | — |